KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Non-Current Debt: 2011-2015

Historic Non-Current Debt for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $30.0 million.

  • Biocryst Pharmaceuticals' Non-Current Debt was N/A to $30.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $30.0 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2014, which is negligibly% changed negligibly from last year.
  • Biocryst Pharmaceuticals' Non-Current Debt amounted to $30.0 million in Q3 2015, which was down 0.00% from $30.0 million recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Non-Current Debt ranged from a high of $30.0 million in Q2 2011 and a low of $30.0 million during Q2 2011.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Non-Current Debt value was $30.0 million (recorded in 2015), while the average stood at $30.0 million.